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Argon Laser Peripheral Iridoplasty (ALPI) versus Systemic Intraocular Pressure (IOP) Lowering 
Medications as the Immediate Management for Acute Phacomorphic Angle Closure
Dr. Jacky W.Y. Lee, Professor Jimmy S.M. Lai
The Eye Institute, The University of Hong Kong
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Comparison between medical therapy vs. ALPI 
Medical therapy 
(n=6)
ALPI
(n=4)
Age 79.7±7.2 years 78.3±11.0 years
Presenting IOP (mmHg) 50.7±8.4 mmHg 50.25±6.9 mmHg 
Presenting VA HM to LP HM to LP
Duration of phacomorphic 
angle closure 2.8±3.5 days 0.9±0.25 days 
IOP 15 mins after treatment 30.1±15.6mmHg 16.5±11.4mmHg 
IOP 30 mins after treatment 29.8±13.5mmHg 15.5±5.3mmHg 
IOP 60 mins after treatment 30.5±14.4mmHg 19±1.7mmHg 
IOP 120 mins after 
treatment 26.3±13.4mmHg 12.8±7.5mmHg
IOP 180 mins after 
treatment 11.7±5.9mmHg 
Not recorded (all 
IOP<25mmHg) 
Percent requiring IV 
mannitol 50% 0
IOP at Day 1 after treatment 15.8±4.2mmHg 16.7±9.0mmHg 
Time from treatment to 
cataract extraction 1.7±0.8 days 1.3±0.5 days 
IOP at 3 months after attack 11.2±4.2 9.5±2.3mHg 
IOP at 9 months after attack 11.2±3.3mmHg 11.5±3.1mmHg
Precent requiring topical 
glaucoma medication 16.7% 0
BCVA at 1 months after 
attack (Snellen) 0.4±0.2 0.4±0.2 
Angle at 3 months after 
attack 35.9±4.6° 38.8±3.6°
PAS at 3 months after attack 45±45.3° 22.5±45°
Endothelial count at 3 
months after attack
1928.5±529.1 
cells/mm2
2379.3±573.3 
cells/mm2
RNFL at 3 months after 88.7±21.6um 102.9±24.4um 
RNFL at 9 months after 78.3±20.5um 96.1±19.1um
VCDR by OCT 3 months after 
attack 0.6±0.2 0.5±0.02 
The amount of IOP reduction within the first 30mins of treatment
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Purpose: To compare the efficacy and safety of ALPI versus systemic IOP lowering medications in the 
immediate management of acute phacomorphic angle closure (a secondary angle closure caused by the 
anterior protrusion of an intumescent cataract resulting in pupil block and irido-trabecular angle closure).
Patients and Methods: This was a prospective randomized controlled study conducted in Hong Kong, China 
from 2009 to 2010. Patients were randomized to receive intravenous (IV) and oral carbonic anhydrase
inhibitor or ALPI as the initial treatment. IV mannitol was administered in both groups for presenting 
IOP>60mmHg or IOP>40mmHg 2 hours post treatment.  All cases received topical Timolol, Atropine, and 
steroids prior to definitive cataract extraction. 
Conclusion:
ALPI is more consistent, safer, and more effective than systemic carbonic anhydrase inhibitor and 
hyperosmotic agents in lowering the IOP during an acute attack of phacomorphic angle closure.
Results:
ALPI offered better results in: 
1) The time taken to lower IOP to 25mmHg (115.0±97.0 mins in the medical group vs. 18.8±7.5 mins in the 
ALPI group; t test p=0.06, F test p=0.001)
2) The reduction of IOP within the first 30 minutes (20.8±13.5mmHg  in the medical group vs. 34.8±3.2mmHg 
in the ALPI group; t test p=0.06, F test p=0.04) 
3) The post attack CDR (0.60±0.20 in the medical group and 0.50±0.02 ALPI group; t test p=0.2, F test=0.002)
The following parameters were comparable in both groups: the degree of peripheral anterior synechiae (PAS) 
formation, angle,  retinal nerve fibre layer, endothelial cell count, post-op visual acuity and post-op IOP
Comparison between medical therapy vs. ALPI Change in IOP: medical vs. ALPI
Time to IOP < 25mmHg
Mins
Medical therapy AL I
Medic l therapy A PI
Amount 
of IOP 
reduced 
(mmHg)
The amount of IPO reduction within the first 
30 minutes of treatment
